Nicola Biagio Mercuri et al.
Trends in pharmacological sciences, 26(7), 341-344 (2005-06-07)
The chronic treatment of Parkinson's disease with L-dopa is often associated with fluctuations of motor response and dyskinesias. Therefore, to overcome the adverse effects of the long-term use of L-dopa, directly acting dopamine receptor agonists have been introduced. However, L-dopa